Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

beta-Secretase

Known as: beta secretase 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Beta secretase (BACE) inhibitors are promising therapeutic compounds currently in clinical phase II/III trials. Preclinical [18F… Expand
2018
2018
Our previous study demonstrated the translocation of Aβ1–42 to the nucleus in response to antibiotic treatment, and interpreted… Expand
  • figure 1
  • figure 2
  • figure 4
Review
2017
Review
2017
While the peripheral nervous system has the capacity to regenerate following a nerve injury, it is often at a slow rate and… Expand
Review
2016
Review
2016
  • Rena Li, Y. Liu
  • Journal of sport and health science
  • 2016
  • Corpus ID: 37374826
Alzheimer’s disease (AD) is an irreversible, progressive brain disorder that affects about 48 million people worldwide and is the… Expand
Highly Cited
2015
Highly Cited
2015
Environmental pollutants act as risk factors for Alzheimer's disease (AD), mainly affecting the aging population. We investigated… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
2014
2014
Beta-secretase is the key enzyme involved in Alzheimer's disease thus; inhibition of the enzyme can lead to a potential anti… Expand
  • figure 2
  • table 2
  • table 3
Review
2014
Review
2014
Alzheimer’s disease (AD) is a complex neurodegenerative disorder with a multi-faceted pathogenesis. So far, the therapeutic… Expand
2012
2012
Un compuesto de Formula (I)**Formula** o un tautomero o una forma estereoisomerica del mismo, en la que R1, R2, R3 se seleccionan… Expand
1996
1996
The insoluble amyloid deposited extracellularly in the brains of patients with Alzheimer's disease (AD) is composed of amyloid… Expand